JDRF’s investment in Israel has been significant, in large part due to its scientists’ international reputation in medical research and biotechnology. The study of the development and function of the insulin-producing beta cell is an interdisciplinary strength of Israeli scientists. JDRF is eager to further joint efforts with stem cell and developmental biology experts in Israel to focus on our vision of beta cell and immune therapies to speed–and achieve–significant advances toward improved treatments and a cure for type 1 diabetes.To learn more about this interesting project, download the following materials:
You can also watch a video of Dr. Shimon Efrat presenting on his recent research.
For more information or to discuss your gift to the JDRF Israel Initiative, please contact:
Kelly Taranto, Associate Executive Director, at (781) 431-0700 or email@example.com.
JDRF has partnered with Jewish Causes of Choice should you wish to make your gift online: www.jchoice.org/JDRF.htm.